Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2020

01-10-2020 | Leprosy | Original Article

Leprosy in the twenty-first century: a microbiological, clinical, and epidemiological study in northwestern Spain

Authors: Gema Barbeito-Castiñeiras, Beatriz Mejuto, Amparo Coira Nieto, María Jesús Domínguez Santalla, Antonio Aguilera Guirao, María Luisa Pérez del Molino

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2020

Login to get access

Abstract

Leprosy, or Hansen’s disease, is a chronic granulomatous disease caused by Mycobacterium leprae and the recently discovered Mycobacterium lepromatosis. In Spain and other countries, where leprosy has been eliminated, an increasing number of imported cases have been documented, especially from South Africa and South America. The diagnosis of leprosy is mainly clinical, based on the signs established by the World Health Organization (WHO), although laboratory tools can be useful for diagnostic confirmation. The treatment is based on the administration of multi-drug therapy, and involves the multidisciplinary work of experts in ophthalmology, orthopedics, and physiotherapy. We studied the confirmed cases by microbiological and /or histopathological diagnosis in the health area of Santiago de Compostela (456,874 inhabitants in Galicia, in the Northwest of Spain), analyzing their clinical, microbiological, and epidemiological characteristics (2006–2015). In our study, we describe five cases of leprosy, four of them imported and one that, in the absence of more data, is native. Although we have only documented five cases during the 10 years of the study, our experience highlights the importance of considering the country of origin, travel history, and contacts in patients or staff working with leprosy patients. Despite the decrease of leprosy in our environment, it is important to enhance suspicion of the disease among health personnel, especially in those patients from countries where leprosy is endemic and those in close contact with the diagnosed patients.
Literature
2.
go back to reference Eichelmann K, González SEG, Ocampo-candiani JCSJ (2013) Lepra : puesta al día . Definición , patogénesis , clasificación , diagnóstico y tratamiento. Actas Dermosifiliogr 104(7):554–563CrossRef Eichelmann K, González SEG, Ocampo-candiani JCSJ (2013) Lepra : puesta al día . Definición , patogénesis , clasificación , diagnóstico y tratamiento. Actas Dermosifiliogr 104(7):554–563CrossRef
11.
go back to reference Pérez del Molino ML, Barbeito-Castiñeiras G, Mejuto B, Alonso P, Fernández A, González-Mediero G et al (2016) The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008–2013). Eur J Clin Microbiol Infect Dis 35(11) Pérez del Molino ML, Barbeito-Castiñeiras G, Mejuto B, Alonso P, Fernández A, González-Mediero G et al (2016) The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008–2013). Eur J Clin Microbiol Infect Dis 35(11)
12.
go back to reference Costa-Alcalde JJ, Barbeito-Castiñeiras G, González-Alba JM, Aguilera A, Galán JC, Pérez-del-Molino ML (2019) Comparative evaluation of the identification of rapidly growing non-tuberculous mycobacteria by mass spectrometry (MALDI-TOF MS), GenoType Mycobacterium CM/AS assay and partial sequencing of the rpoβ gene with phylogenetic analysis as a reference method. Enferm Infecc Microbiol Clin 37(3):160–166 Available from: http://www.sciencedirect.com/science/article/pii/S0213005X18301873CrossRef Costa-Alcalde JJ, Barbeito-Castiñeiras G, González-Alba JM, Aguilera A, Galán JC, Pérez-del-Molino ML (2019) Comparative evaluation of the identification of rapidly growing non-tuberculous mycobacteria by mass spectrometry (MALDI-TOF MS), GenoType Mycobacterium CM/AS assay and partial sequencing of the rpoβ gene with phylogenetic analysis as a reference method. Enferm Infecc Microbiol Clin 37(3):160–166 Available from: http://​www.​sciencedirect.​com/​science/​article/​pii/​S0213005X1830187​3CrossRef
13.
go back to reference Murray PR. Manual of clinical microbiology. 10th ed. Press A, editor. Washington, DC; 2011 Murray PR. Manual of clinical microbiology. 10th ed. Press A, editor. Washington, DC; 2011
16.
go back to reference Wolff K, Fitzpatrick T, Johnson R (2011) Atlas en color y sinopsis de dermatología clínica. McGraw-Hill Interamericana, Madrid Wolff K, Fitzpatrick T, Johnson R (2011) Atlas en color y sinopsis de dermatología clínica. McGraw-Hill Interamericana, Madrid
17.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416CrossRef Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416CrossRef
19.
go back to reference Soto A, Torres MP (2015) Leprosy diagnosis: an update on the use of molecular tools. Lucrecia Mol Biol 4(139) Soto A, Torres MP (2015) Leprosy diagnosis: an update on the use of molecular tools. Lucrecia Mol Biol 4(139)
Metadata
Title
Leprosy in the twenty-first century: a microbiological, clinical, and epidemiological study in northwestern Spain
Authors
Gema Barbeito-Castiñeiras
Beatriz Mejuto
Amparo Coira Nieto
María Jesús Domínguez Santalla
Antonio Aguilera Guirao
María Luisa Pérez del Molino
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Keyword
Leprosy
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-03911-x

Other articles of this Issue 10/2020

European Journal of Clinical Microbiology & Infectious Diseases 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.